Kaliki S - Search Results

1

Presumed Natural History of Combined Hamartoma of the Retina and Retinal Pigment Epithelium.

Ledesma-Gil G, Essilfie J, Gupta R, Fung AT, Lupidi M, Pappuru RR, Nayak S, Sahoo NK, Kaliki S, Yannuzzi LA, Reid K, Lim L, Sacconi R, Dave V, Singh SR, Ayachit A, Gabrielle PH, Cai S, Lima LH, Querques G, Arevalo JF, Freund KB, Shields CL, Chhablani J. Ledesma-Gil G, et al. Among authors: kaliki s. Ophthalmol Retina. 2021 Nov;5(11):1156-1163. doi: 10.1016/j.oret.2021.01.011. Epub 2021 Jan 28. Ophthalmol Retina. 2021. PMID: 33516918

2

Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.

Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA. Shields CL, et al. Among authors: kaliki s. Ophthalmology. 2012 Jan;119(1):188-92. doi: 10.1016/j.ophtha.2011.06.036. Epub 2011 Oct 5. Ophthalmology. 2012. PMID: 21975042

3

Postenucleation adjuvant chemotherapy with vincristine, etoposide, and carboplatin for the treatment of high-risk retinoblastoma.

Kaliki S, Shields CL, Shah SU, Eagle RC Jr, Shields JA, Leahey A. Kaliki S, et al. Arch Ophthalmol. 2011 Nov;129(11):1422-7. doi: 10.1001/archophthalmol.2011.289. Arch Ophthalmol. 2011. PMID: 22084213

4

Effect of intraarterial chemotherapy on retinoblastoma-induced retinal detachment.

Shields CL, Kaliki S, Shah SU, Bianciotto CG, Jabbour P, Shields JA. Shields CL, et al. Among authors: kaliki s. Retina. 2012 Apr;32(4):799-804. doi: 10.1097/IAE.0b013e31823d8e1e. Retina. 2012. PMID: 22105496

5

Recent trends in ocular oncology.

Kaliki S, Shields CL. Kaliki S, et al. Oman J Ophthalmol. 2011 Sep;4(3):103-4. doi: 10.4103/0974-620X.91263. Oman J Ophthalmol. 2011. PMID: 22279395 Free PMC article. No abstract available.

6

Enhanced depth imaging optical coherence tomography of choroidal nevus in 104 cases.

Shah SU, Kaliki S, Shields CL, Ferenczy SR, Harmon SA, Shields JA. Shah SU, et al. Among authors: kaliki s. Ophthalmology. 2012 May;119(5):1066-72. doi: 10.1016/j.ophtha.2011.11.001. Epub 2012 Jan 31. Ophthalmology. 2012. PMID: 22297027

7

Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.

Shah SU, Kaliki S, Kim HJ, Lally SE, Shields JA, Shields CL. Shah SU, et al. Among authors: kaliki s. Arch Ophthalmol. 2012 Feb;130(2):159-64. doi: 10.1001/archophthalmol.2011.385. Arch Ophthalmol. 2012. PMID: 22332208

8

Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.

Kim HJ, Shields CL, Shah SU, Kaliki S, Lally SE. Kim HJ, et al. Among authors: kaliki s. Ophthalmology. 2012 May;119(5):938-44. doi: 10.1016/j.ophtha.2011.11.035. Epub 2012 Feb 22. Ophthalmology. 2012. PMID: 22361315

9

Iris melanoma: features and prognosis in 317 children and adults.

Shields CL, Kaliki S, Shah SU, Luo W, Furuta M, Shields JA. Shields CL, et al. Among authors: kaliki s. J AAPOS. 2012 Feb;16(1):10-6. doi: 10.1016/j.jaapos.2011.10.012. J AAPOS. 2012. PMID: 22370659

10

Asymmetry of familial exudative vitreoretinopathy.

Shukla SY, Kaliki S, Shields CL. Shukla SY, et al. Among authors: kaliki s. J Pediatr Ophthalmol Strabismus. 2012 Feb 28;49 Online:e5-8. doi: 10.3928/01913913-20120221-01. J Pediatr Ophthalmol Strabismus. 2012. PMID: 22372757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

290 results

Search Page

Filters